UCLA Hematology Oncology Center - Main Site

Site:	UCLA Hematology Oncology Center - Main Site
Address:
City:	Los Angeles
State:	CA
Zip:	90024
Country:	USA

Phase	Trial	Trial Status	Site Status [desc]	Drug	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501